The Valley Desk

ArticleJournal for immunotherapy of cancerPublished

Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University Hospital, with Jefferson Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Journal for immunotherapy of cancer
Published
Subject terms
Humans; Endometrial Neoplasms; Phenylurea Compounds; Quinolines; RNA; Female; Antibodies, Monoclonal, Humanized; Biomarkers, Tumor; Immunotherapy; Tumor Biomarkers
PubMed ID
38242717
PubMed Central ID
PMC10806562
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal